Answers are grounded in this paper and cite their sources.
Findings demonstrate SNRPD2's role in gliomas' disease aggressiveness, highlighting potential therapeutic targets.
These data establish SNRPD2 and its associated alternatively spliced repertoire as a central adaptive node linked to disease aggressiveness in gliomas, highlighting it as a potential therapeutic target in glioma patients.
No takes yet. Share an insight, caveat, or question.
LI et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: